Aiosyn Mitosis Breast becomes the first AI-powered mitosis detection solution to achieve CE mark certification under IVDR
recent articles
Proscia & Bioptimus: Explore how foundation models can transform novel AI development in pathology Unlocking the Promise of Foundation Models in Pathology for AI-Driven Drug Discovery & Development November 6, 11:00 AM — 12:00...
Oxford, UK – 15/10/2024 – Diagnexia, the clinical digital pathology service of Deciphex, proudly announces the opening of a new, cutting-edge histopathology laboratory in Oxford. This advanced facility is set to significantly expand...
Bioptimus’ H-optimus-0 Foundation Model Now Available with Proscia’s Concentriq® Embeddings for Rapid AI Development With 1.1 billion parameters, H-optimus-0 is the largest open-source AI foundation model tailored specifically for...
Aiosyn announces webinar for next month November 5 4:00 PM CET | 10:00 AM ET | 7:00 AM PT REGISTER NOW Join us for our 45-minute webinar where we explore the challenges of manual quality control (QC) in digital pathology and how...
New from GE HealthCare: Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving...
Proscia: 2024 Emerging Solutions Top 20 winners celebrated at HLTH USA PHILADELPHIA – OCTOBER 22, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, was named to KLAS Research’s 2024 Emerging...
